Drug Discovery & Pharmaceuticals

RSS

CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS). Building upon the Company's FDA-recognized drug induced liver injury (DILI) assay, the expanded offering enables rapid, comparative studies between commonly used animal and human models to flag interspecies differences early, and better informs in vivo study design.

10 Jun 2025

New anti-aging compounds found hidden beneath the skin

People go to great lengths to maintain youthful-looking skin with masks, creams and serums. Now, researchers have discovered compounds with anti-aging properties hidden beneath our own skin.

5 Jun 2025

LabGenius Therapeutics appoints Dr. Angus Sinclair as Chief Scientific Officer

LabGenius Therapeutics (“LabGenius”) is a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimize complex therapeutic antibodies, including those with multispecific designs.

4 Jun 2025

Fujifilm rebrands Life Sciences Companies to strengthen position as strategic partners for life, offering end-to-end solutions

FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialization, today announced new names and identities as part of a strategic positioning effort.

3 Jun 2025

New compound infuzide shows promise against resistant bacterial infections

Antimicrobial resistance directly causes more than 1 million deaths every year and contributes to more than 35 million more, according to the World Health Organization. Staphylococcus aureus and Enterococcus sp., 2 gram-positive pathogens highly likely to develop resistance to known treatments, can cause dangerous hospital-acquired and community-acquired infections.

2 Jun 2025

Sartorius launches the Octet® R8e System: Real-time, label-free biomolecular interaction analysis with unprecedented sensitivity and efficiency

The life science group Sartorius launches the new Octet® R8e biolayer interferometry (BLI) system, providing researchers with its most advanced detection capabilities to date for real-time, high-throughput analysis of protein-protein, protein-small molecule, and other biomolecular interactions.

24 May 2025

Closed Loop Medicine appoints Kate Woolland as CEO

Closed Loop Medicine Ltd. (“CLM”), a leader in pharmaceutical precision dosing, today announced the appointment of Kate Woolland as Chief Executive Officer.

22 May 2025

Perceptive eclinical launches Clinphone Pro: An innovative RTSM platform built by RTSM experts for RTSM experts

Perceptive eClinical unveils ClinPhone Pro, a next-generation RTSM platform. Built on over 30 years of experience, ClinPhone Pro integrates seamlessly within the clinical technology ecosystem, offering advanced drug supply simulation and rolling forecast capabilities.

From Perceptive 21 May 2025

Astoriom expands global footprint for sample stability storage services

Astoriom, a global leader in the R&D sample stability and biorepository storage industry, today announced that it has expanded the stability storage capabilities at its Tramore site in Ireland to meet demand for scalable, flexible, regulatory-compliant storage solutions from -60 °C to -196 °C and ICH (International Council for Harmonisation) temperature-controlled stability conditions.

20 May 2025

CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced a strategic partnership with SCINCO, a specialist scientific instrument company based in South Korea.

20 May 2025

Headway in Alzheimer’s disease care: New guidance provides recommendations for use of anti-amyloid monoclonal antibodies

The new guidelines for the use of monoclonal antibodies (mAbs) published in Neurodegenerative Diseases, serve as exemplary clinical recommendations for clinicians and healthcare providers, supporting the advancement of Alzheimer's disease treatment in Switzerland.

From S. Karger AG 19 May 2025

Aptamer announces new data at ASGCT

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025).

From Aptamer Group 16 May 2025

New candidate compounds show promise for Alzheimer's and pain treatment

A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of Alzheimer's disease and pain, which have shown promising effects in animal models.

14 May 2025

New glycopeptide antibiotic discovered to combat resistant bacteria

An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland, has discovered saarvienin A, a new type of glycopeptide antibiotic.

14 May 2025

Solgate streamlines SLC drug discovery with INTEGRA's automated pipetting systems

Solgate - a biotech start-up based in Klosterneuburg, Austria - is accelerating the development of new therapies targeting solute carrier (SLC) transporters using automated liquid handling systems from INTEGRA Biosciences.

14 May 2025

PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced Barbara Duncan has joined its Board as Chair, and Stephen Dilly as Non-Executive Director.

From PhoreMost 12 May 2025

ELRIG announces keynote speakers for Drug Discovery 2025

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, has revealed the keynote speakers for its flagship event, Drug Discovery 2025. Taking place at the ACC in Liverpool, UK from 21-22 October, the conference will feature presentations from Professor Heather Pinkett (Northwestern University) and Dr Dafydd Owen (Pfizer Medicine Design).

From ELRIG (UK) Ltd. 12 May 2025

Waters integrates Multi-Angle Light Scattering Detectors with empower software for improved biologics quality control and simplified regulatory compliance

Waters Corporation today announced that its Empower™ Software now supports biologics data acquisition and quality control (QC) analysis from Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments in its Wyatt Technology™ Portfolio.

From Waters Corporation 7 May 2025

New rifamycin drugs fight antibiotic-resistant lung infections more effectively

Researchers have developed next-generation rifamycin analogs that effectively kill both replicating and nonreplicating Mycobacterium abscessus while minimizing drug-drug interactions. Lead candidates UMN-120 and UMN-121 showed superior efficacy to current treatments in mouse models and retained potency against M. tuberculosis.

5 May 2025

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron. The models demonstrated faster, cheaper, and more adaptable therapeutic development compared to traditional methods.

5 May 2025

Drug Discovery & Pharmaceuticals

CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development

New anti-aging compounds found hidden beneath the skin

LabGenius Therapeutics appoints Dr. Angus Sinclair as Chief Scientific Officer

Fujifilm rebrands Life Sciences Companies to strengthen position as strategic partners for life, offering end-to-end solutions

New compound infuzide shows promise against resistant bacterial infections

Sartorius launches the Octet® R8e System: Real-time, label-free biomolecular interaction analysis with unprecedented sensitivity and efficiency

Closed Loop Medicine appoints Kate Woolland as CEO

Perceptive eclinical launches Clinphone Pro: An innovative RTSM platform built by RTSM experts for RTSM experts

Astoriom expands global footprint for sample stability storage services

CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea

Headway in Alzheimer’s disease care: New guidance provides recommendations for use of anti-amyloid monoclonal antibodies

Aptamer announces new data at ASGCT

New candidate compounds show promise for Alzheimer's and pain treatment

New glycopeptide antibiotic discovered to combat resistant bacteria

Solgate streamlines SLC drug discovery with INTEGRA's automated pipetting systems

PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics

ELRIG announces keynote speakers for Drug Discovery 2025

Waters integrates Multi-Angle Light Scattering Detectors with empower software for improved biologics quality control and simplified regulatory compliance

New rifamycin drugs fight antibiotic-resistant lung infections more effectively

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest Life Science News